Botulinum toxin cosmetic therapy correlates with a more positive mood

Journal of Cosmetic Dermatology

Volumn 8, Issue 1, 2009, Pages 24-26

  Lewis, Michael B ^a   Bowler, Patrick J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Court House Clinics ^*  (United Kingdom)

Author keywords

Botulinum toxin A; Depression; Facial feedback; Glabelar frown lines; Mood

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COSMETIC THERAPY; DEPRESSION; DRUG RESPONSE; FACIAL EXPRESSION; GLABELAR FROWN LINE; HUMAN; IRRITABILITY; MOOD CHANGE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; THERAPY; TREATMENT DURATION; WRINKLE; AFFECT; AGING; CASE CONTROL STUDY; CUTANEOUS PARAMETERS; DRUG EFFECT; ESTHETIC SURGERY; ESTHETICS; EVALUATION; FEMALE; FOLLOW UP; MENTAL STRESS; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; PSYCHOLOGICAL ASPECT; REJUVENATION; SELF CONCEPT; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

AFFECT; AGING; BOTULINUM TOXIN TYPE A; CASE-CONTROL STUDIES; COSMETIC TECHNIQUES; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; REJUVENATION; SELF CONCEPT; SKIN AGING; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 67049114735     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00419.x     Document Type: Article

References (11)

1. Strack F, Martin LL, Stepper S. Inhibiting and facilitating conditions of human smile: A nonobtrusive test of the facial feedback hypothesis. J Pers Soc Psychol 1988; 54: 768-77.
2. Strack F, Neumann R. Furrowing the brow may undermine perceived fame: the role of facial feedback in judgments of celebrity. Pers Soc Psychol B, 2000; 26: 762-8.
3. Twerski AJ, Twerski B. The emotional impact of facial paralysis. In: May M, ed. The Facial Nerve. New York: Thieme; 1986.
4. Van Swearingen JM, Cohn JF, Bajaj-Luthra A. Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthet Plast Surg, 1999; 23: 416-23.
5. Carruthers JA, Lowe NJ, Menter MA et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46: 840-9.
6. Ekman P. About brows: Emotional conversational signals. In: M Cranach, K Froppa, W Lepenies, D Ploog, eds. Human Ethology, Claims and Limits of a New Discipline. Cambridge, UK: Cambridge University Press; 1978.
7. Heckmann M, Teichmann B, Schröder U, Sprengelmeyer R, Ceballos-Baumann A. Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. J Am Acad Dermatol 2002; 49: 213-6.
8. Finzi E, Wasserman E. Treatment of depression with botulinum toxin A: A case series. Dermatol Surg 2006; 32: 645-50.
9. Carruthers A, Hammond M. Commentary on Finzi & Wasserman (2006). Dermatol Surg 2006; 32: 650-1.
10. Sommer B, Zschocke I, Bergfeld D, Sattler G, Augustin M. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg 2003; 29: 456-60.
11. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale with the Irritability-Depression-Anxiety Scale. London, UK: NferNelson; 1994.